Pricing Log in Create free account

Senesco Technologies Inc. (ELOX) vs Kalaris Therapeutics Inc. (KLRS)

Senesco Technologies Inc. and Kalaris Therapeutics Inc. are both Biotechnology companies. Senesco Technologies Inc. and Kalaris Therapeutics Inc. are of similar size ($51.7M and $51.6M). Across the 8 metrics below, Kalaris Therapeutics Inc. leads on 5 and Senesco Technologies Inc. on 3.

Valuation

Metric ELOX KLRS Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 1.82 1.01 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.33 0.66
EV/Sales n/m n/m 9.02
Earnings yield (95.90%) (85.64%) (32.88%)
Free cash flow yield (12.35%) (70.40%) (23.13%)

Profitability

Metric ELOX KLRS Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (89.91%) (79.91%) (51.96%)
Return on assets (34.15%) (46.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELOX KLRS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 41.93% 94.50% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELOX KLRS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.74 10.98 4.97
Net debt to EBITDA 0.61 2.54 1.01

Dividend

Metric ELOX KLRS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELOX KLRS Biotechnology median
Market cap 51.66m 51.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack